Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach

Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach

Saved in:

Bibliographic Details
Main Author:	Shyam Srinivasan
Format:	Article
Language:	English
Published:	Wiley 2024-10-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.994
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01)

Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia
by: Federico Mosna, et al.
Published: (2016-01-01)

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01)

Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
by: Monika Conchon, et al.
Published: (2010-01-01)

Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia
by: Avery Watson, M4, et al.
Published: (2025-07-01)

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
by: Andrew Stevenson Joel Chandranesan, et al.
Published: (2018-01-01)

Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
by: TI Ionova, et al.
Published: (2017-04-01)

Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
by: Wenlan Chen, et al.
Published: (2016-01-01)

A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
by: Samer Alsidawi, et al.
Published: (2014-01-01)

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)

Dasatinib-induced renal (or chronic) thrombotic microangiopathy in a patient with chronic myeloid leukemia: A case report
by: Ryan Sabour, et al.
Published: (2025-02-01)

Gelatinous Marrow Transformation in Chronic Myeloid Leukemia Post-Dasatinib Treatment: A Case Report with Review of Literature
by: Gayathri Kini, et al.

Retracted: Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Dasatinib-Induced lymphocytosis and pleural effusion in a patient of chronic myeloid leukemia: A rare Indian case report
by: Ashish Joshi, et al.
Published: (2020-01-01)

The Functional and Prognostic Impact of TIGIT Expression on Bone Marrow NK Cells in Core Binding Factor-Acute Myeloid Leukemia Patients at Diagnosis
by: Dai-Hong Xie, et al.
Published: (2024-09-01)

Functional Role of Fatty Acid Synthase for Signal Transduction in Core-Binding Factor Acute Myeloid Leukemia with an Activating c-Kit Mutation
by: Ruimeng Zhuang, et al.
Published: (2025-03-01)

Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target
by: Mengnan Liu, et al.
Published: (2025-07-01)

Selinexor in acute myeloid leukemia: therapeutic applications and current challenges
by: Ziyu Qie, et al.
Published: (2025-05-01)

Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of <i>BCR::ABL1/A337V</i> Can Be Effectively Overcome with Dasatinib Treatment
by: Peter Batar, et al.
Published: (2025-02-01)

Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia
by: Xiaokang Wang, et al.
Published: (2025-07-01)

Ferroptosis determinants – potential predictors and therapeutic targets for acute myeloid leukemia
by: V. E. Shevchenko, et al.
Published: (2025-06-01)

A bioinformatics analysis and experimental validation of PDGFD as a promising diagnostic biomarker for acute myeloid leukemia
by: Lulu Yang, et al.
Published: (2025-04-01)

What Is Acute Myeloid Leukemia?
by: Daniel Mazza Matos, et al.
Published: (2025-06-01)

Therapeutic strategy in acute myeloid leukemia – the experience of a single Portuguese institution
by: Ana Espirito Santo, et al.
Published: (2014-08-01)

Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies
by: Venkata Lokesh Battula, et al.
Published: (2024-02-01)

Targeting METTL3 protein by proteolysis-targeting chimeras: A novel therapeutic approach for acute myeloid leukemia
by: Rukiye Nar, et al.
Published: (2025-07-01)

To Augment or Not to Augment Consolidation Therapy for High-Risk Childhood Acute Lymphoblastic Leukemia
by: Shyam Srinivasan
Published: (2024-02-01)

Acute Myeloid Leukemia Presenting as Acute Appendicitis
by: Sherri Rauenzahn, et al.
Published: (2013-01-01)

Acute Myeloid Leukemia Relapse Presenting as Complete Monocular Vision Loss due to Optic Nerve Involvement
by: Shyam A. Patel
Published: (2016-01-01)

Cytogenetic and Molecular Genetic Prognostic Factors of Acute Myeloid Leukemia
by: AV Misyurin
Published: (2017-04-01)

Socioeconomic Factors Influencing Treatment and Outcomes in Acute Myeloid Leukemia
by: Priscilla Nethala, et al.
Published: (2025-01-01)

Clonal hematopoiesis and acute myeloid leukemia
by: A. I. Kashlakova, et al.
Published: (2023-09-01)

Epidemiology of Acute Myeloid Leukemia (AML)
by: Gengi Kleto, et al.

Treatment of acute myeloid leukemia in children
by: A. V. Popa, et al.
Published: (2022-11-01)

Genetic Mutations in Acute Myeloid Leukemia
by: OV Blau
Published: (2016-07-01)

The Epigenetic Landscape of Acute Myeloid Leukemia
by: Emma Conway O’Brien, et al.
Published: (2014-01-01)

Acute Myeloid Leukemia with NUP98: : LNP1 Fusion Mimicking Chronic Myeloid Leukemia
by: Haiyang Wang, et al.
Published: (2025-06-01)

Quality of life, symptom profile and clinical efficacy of second-line treatment with dasatinib in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: results of 2-year follow-up
by: T. I. Ionova, et al.
Published: (2015-10-01)

Diagnostic value of circular RNAs as promising hematological biomarkers in acute myeloid leukemia: A systematic review and meta-analysis
by: Amir Hossein Aghayan, et al.
Published: (2025-05-01)

Evolution of therapeutic approaches in patients with chronic myeloid leukemia and T315I mutation
by: A. G. Turkina, et al.
Published: (2024-12-01)